Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Infliximab IBD Influenza Vaccine Study

This study has been completed.
Janssen Inc.
Information provided by (Responsible Party):
Jennifer deBruyn, University of Calgary Identifier:
First received: August 8, 2012
Last updated: May 5, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)